Home>Stocks>Sakar Healthcare Limited
S
bookmark_border
share

Sakar Healthcare

NaN
NaN (NaN%) 1D
NSE
1D
1W
1M
1Y
3Y
5Y

Fundamentals

Market Cap₹252Cr
P/E Ratio20.66
P/B Ratio2.34
Industry P/ENA
ROE11.88%
EPS(TTM)7.13
Dividend YieldNA
Book Value63.04
Understand Fundamentals
info

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly
See Details

About Company

Sakar Healthcare ltd. is an India-based company, which is engaged in the manufacturing of pharmaceutical products. The Company is engaged in providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Liquid Injectables in ampoules and vials, and Dry Powder Injections. It also provides Lyophilized Injectables. The Company operates as contract manufacturer for multinational pharmaceutical companies. The Company's products include Albendazole oral suspension USP, Cetirizine hydrochloride syrup, Cefadroxil and potassium clavulanate tablets, Cefixime and potassium clavulanate tablets, Cefpodoxime proxetil Capsule, Cefalexin oral suspension BP, Cefixime for oral suspension, Cefuroxime Axetil tablets BP, Adrenallin tartrate Injection, Quinine dihydrochloride Injection, Vitamin B-complex Injection, Chloroquine phosphate Injection, Tranexamic Acid Injection, Palonosetron hydrochloride Injection and others. The Company has its presence in approximately 40 countries.
... Read More
Parent OrganisationSakar Healthcare Limited
Founded2004
Managing DirectorNA
NSE SymbolSAKAR
ⓒ 2016-2021 Groww. All rights reserved, Built with in India
ABOUT GROWW
keyboard_arrow_down